Table 2.
Logistic regression analysis of subjects with moderate to severe PVWMH and DSWMH.
| Moderate to severe PVWMH | p | Moderate to severe DSWMH | p | |
|---|---|---|---|---|
| OR (95% CIs) | OR (95% CIs) | |||
| Gender (male) | 0.95 (0.65–1.38) | 0.786 | 0.89 (0.62–1.27) | 0.518 |
| Age | 1.13 (1.10–1.16) | <0.001 | 1.09 (1.07–1.12) | <0.001 |
| Hypertension | 1.78 (1.26–2.50) | 0.001 | 1.59 (1.15–2.20) | 0.005 |
| Diabetes mellitus | 1.61 (1.12–2.31) | 0.009 | 0.97 (0.68–1.38) | 0.849 |
| Hypercholesterolemia | 0.97 (0.61–1.55) | 0.883 | 1.63 (1.05–2.53) | 0.030 |
| Current smoking status | 1.15 (0.74–1.80) | 0.541 | 1.09 (0.71–1.67) | 0.692 |
| CAOD | 1.14 (0.60–2.16) | 0.697 | 0.64 (0.32–1.28) | 0.205 |
| Statin medication | 0.56 (0.33–0.96) | 0.035 | 0.52 (0.32–0.86) | 0.011 |
| eGFR | 0.63 (0.43–0.92) | 0.017 | 0.99 (0.68–1.45) | 0.961 |
| Hcyt | 1.06 (1.02–1.09) | 0.002 | 1.02 (0.99–1.06) | 0.150 |
PVWMH, periventricular white matter hyperintensities; DSWMH, deep subcortical white matter hyperintensities; CAOD, coronary arterial occlusive disease; eGFR, estimated glomerular filtration rate; Hcyt, plasma total homocysteine; OR, odds ratio; CIs, confidence intervals.